Immunogenicity of bacteriophage lambda particles displaying porcine Circovirus 2 (PCV2) capsid protein epitopes

被引:44
作者
Gamage, Lakshman N. A. [2 ]
Ellis, John [2 ]
Hayes, Sidney [1 ]
机构
[1] Univ Saskatchewan, Coll Med, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada
[2] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK S7N 5E5, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
Phage display vaccine; Bacteriophage lambda; Porcine Circovirus 2; PCV2 ORF2 capsid protein; MULTISYSTEMIC WASTING SYNDROME; TYPE-2; PCV2; IMMUNE-RESPONSES; CELL-LINE; VACCINE; PIGS; PHAGE; EXPRESSION; ANTIBODIES; VIRUS;
D O I
10.1016/j.vaccine.2009.08.019
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Phage lambda particles displaying four immunodominant regions of porcine Circovirus 2 (PCV2) capsid protein (LDP-D-CAP) was shown to be immunogenic in pigs. The immunodominant regions were fused to the carboxyl-terminal of lambda head protein D. Expression of D-CAP on lambda display particles was demonstrated by ELISA and Western blots. Pigs receiving LDP-D-CAP, without incorporating adjuvant, showed significant anti-PCV2 immune response following the primary vaccination. The LDP-D-CAP preparation induced PCV2 neutralizing antibodies. Delayed type hypersensitivity (DTH) reaction scores revealed that the immunized pigs were hypersensitive to both lambda Phaga and PCV2 antigens. The LDP-D-CAP elicited both cellular and humoral immune responses. Neither LDP-D-CAP nor the lambda control elicited any untoward local or systemic reactions following immunization. These studies produced the first potential phage vaccine to porcine Circovirus 2. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6595 / 6604
页数:10
相关论文
共 55 条
[1]   Modulation of toll-like receptor 9 responses through synthetic immunostimulatory motifs of DNA [J].
Agrawal, S ;
Kandimalla, ER .
THERAPEUTIC OLIGONUCLEOTIDES: ANTISENSE, RNAI, TRIPLE-HELIX, GENE REPAIR, ENHANCER DECOYS, CPG AND DNA CHIPS, 2003, 1002 :30-42
[2]   PRODUCTION, PRELIMINARY CHARACTERIZATION AND APPLICATIONS OF MONOCLONAL-ANTIBODIES TO PORCINE CIRCOVIRUS [J].
ALLAN, GM ;
MACKIE, DP ;
MCNAIR, J ;
ADAIR, BM ;
MCNULTY, MS .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1994, 43 (04) :357-371
[3]   Porcine circoviruses: a review [J].
Allan, GM ;
Ellis, JA .
JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION, 2000, 12 (01) :3-14
[4]  
[Anonymous], PCV2 VACCINES
[5]  
[Anonymous], 2009, PORCINE CIRCOVIRUS T
[6]   Vaccination: A management tool in veterinary medicine [J].
Babiuk, LA .
VETERINARY JOURNAL, 2002, 164 (03) :188-201
[7]   NONEPITOPE-SPECIFIC SUPPRESSION OF THE ANTIBODY-RESPONSE TO HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE VACCINES BY PREIMMUNIZATION WITH VACCINE COMPONENTS [J].
BARINGTON, T ;
SKETTRUP, M ;
JUUL, L ;
HEILMANN, C .
INFECTION AND IMMUNITY, 1993, 61 (02) :432-438
[8]   Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus [J].
Bastien, N ;
Trudel, M ;
Simard, C .
VIROLOGY, 1997, 234 (01) :118-122
[9]   Effect of pre-existing carrier immunity on the efficacy of synthetic influenza vaccine [J].
Ben-Yedidia, T ;
Arnon, R .
IMMUNOLOGY LETTERS, 1998, 64 (01) :9-15
[10]   Biotechnological applications of phage and cell display [J].
Benhar, I .
BIOTECHNOLOGY ADVANCES, 2001, 19 (01) :1-33